Latest News:

February User Metrics for PSYC’s Psychedelic Spotlight Platform Reflect Impressive Growth Rate of 40% (PSYC)
Sunshine Biopharma Receives Recently Ordered New Batch of Adva-27a and Initiates QA/QC Testing (SBFM)
Sable Receives 4,552 g/t Silver Equivalent (3,840 g/t Ag; 19.8% Pb; 0.56% Cu) at El Fierro, Extends La Verde Vein Zone to 4.1 km Length (SBLRF)
Intermap Reaches New Milestone Serving Global Unmanned Aircraft and Systems (UAS) with Wingcopter Subscription (ITMSF)
Barrel Energy Signs MOU With American Lithium Minerals for Lithium Battery Production Facilities (AMLM)

Stock Day Media

Ticker Tape by TradingView

News
Radio Show
- Be on our Show!
- Video Interviews
Technology
Cannabis
Energy
BioTech
Mining
Contact Us
- About Us
- Suggestion Box

Subscribe to the latest in penny stock micro-cap news and stock podcasts, straight to your inbox.
Subscribe Now

Radio Interviews

Featured Interview: Guy Chamberland, Chief Scientific Officer of Tetra Bio-Pharma Inc. (OTCQB: GRPOF)

April 25, 2017April 24, 2017 Marcus Heatherly 348 Views Aphria, cannabis research & development, Dronabinol, GRPOF, Guy Chamberland, IntelGenx Corp, Other Stocks

The CSO of Tetra Bio-Pharma, Guy Chamberland joins the show to discuss development of Cannabis based pharmaceutical drugs, late phased development, key partnerships, and the commercialization of new products.

The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.

← Interview: CEO Jean Ekobo of BioNovelus, Inc. (OTCPink: ONOV)
Holiday Island Holdings, Inc. Announces Deal in Principle for Medical Clinics Purchase →

You May Also Like

Dr. George Anastassov, CEO of Axim Biotechnologies, talks Developing Delivery Method for CBD

September 12, 2016 Marcus Heatherly 0

Featured Interview: President George Rutherford of Optium Cyber Systems, Inc. (OTCPink: OCSY)

June 28, 2018 Marcus Heatherly 0

Featured Interview: CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY)

January 14, 2019 Marcus Heatherly Comments Off on Featured Interview: CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY)

Latest News

February User Metrics for PSYC’s Psychedelic Spotlight Platform Reflect Impressive Growth Rate of 40% (PSYC)

March 4, 2021 Stock Day Media Comments Off on February User Metrics for PSYC’s Psychedelic Spotlight Platform Reflect Impressive Growth Rate of 40% (PSYC)

Growth of Psychedelic Spotlight Creates Potential Revenue Opportunities for PSYC LAS VEGAS, NV, March 04, 2021 (GLOBE NEWSWIRE) — Global Trac

Sunshine Biopharma Receives Recently Ordered New Batch of Adva-27a and Initiates QA/QC Testing (SBFM)

March 4, 2021 Stock Day Media Comments Off on Sunshine Biopharma Receives Recently Ordered New Batch of Adva-27a and Initiates QA/QC Testing (SBFM)

Sable Receives 4,552 g/t Silver Equivalent (3,840 g/t Ag; 19.8% Pb; 0.56% Cu) at El Fierro, Extends La Verde Vein Zone to 4.1 km Length (SBLRF)

March 4, 2021 Stock Day Media Comments Off on Sable Receives 4,552 g/t Silver Equivalent (3,840 g/t Ag; 19.8% Pb; 0.56% Cu) at El Fierro, Extends La Verde Vein Zone to 4.1 km Length (SBLRF)

Intermap Reaches New Milestone Serving Global Unmanned Aircraft and Systems (UAS) with Wingcopter Subscription (ITMSF)

March 4, 2021 Stock Day Media Comments Off on Intermap Reaches New Milestone Serving Global Unmanned Aircraft and Systems (UAS) with Wingcopter Subscription (ITMSF)

Copyright © 2021 Stock Day Media. All rights reserved.